Current position

David Einhorn’s Viatris Inc (VTRS) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

DME Capital ManagementVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2024Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares7.40MHighest verified quarter-end share count
Quarters reported7Verified quarters with shares above zero
What happened?

DME Capital Management first reported Viatris Inc in Q1 2024. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. DME Capital Management currently reports 2.77M shares. The latest verified filing showed: Bought 52.6% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 52.6% more+955.90K shares · 2.77M shares reported after the change
Filing context

Quarter-end price $15.88 · Estimated holding basis $14.33

Q1 2026
New position+1.82M shares · 1.82M shares reported
Filing context

Quarter-end price $13.51 · Estimated holding basis $13.51

Q2 2025
Sold the entire position−6.00M shares · No shares reported at quarter-end
Q1 2025
Bought 3.7% more+215.72K shares · 6.00M shares reported after the change
Filing context

Quarter-end price $8.71 · Estimated holding basis $11.33

Q4 2024
Sold 20.4% of the position−1.49M shares · 5.79M shares remained
Filing context

Quarter-end price $12.45 · Estimated holding basis $11.43

Q3 2024
Sold 1.7% of the position−129.38K shares · 7.27M shares remained
Filing context

Quarter-end price $11.61 · Estimated holding basis $11.43

Portfolio importance

How important is Viatris Inc in DME Capital Management’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight1.1%Q2 2026
Current rank#33of 46 reported positions
Peak portfolio weight3.8%Q2 2024
Best historical rank#8Q4 2024
At peak importanceQ2 2024
VTRS
3.8%
Largest holding
29.3%
Cross-investor discovery

Who else owns Viatris Inc?

Also reported by 2 other tracked investors in their latest verified filings.

Joel GreenblattGotham Asset Management
VTRS0.2% of reported portfolio
Ray DalioBridgewater Associates, LP
VTRS0.1% of reported portfolio
Explore Viatris Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$16.512026-09-11

Market context only; not an investor transaction price.

Latest filing quarter-end price$15.88Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$14.33Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

SEC history uses the documented manager succession from Greenlight Capital Inc. to DME Capital Management, LP. This tracker reflects public Form 13F disclosures, not David Einhorn’s personal brokerage account or exact trade dates.